Aarti Industries’ operating profit margin declined at 21.8 percent in Q2FY21 but its pharma business outperformed.

Share Market Live

NSE

Rajendra V Gogri, CMD of Aarti Industries, in an interview with CNBC-TV18, said, “We are trying to diversify the market so that we are able to sustain volume.”

“Domestic sector has reached pre-COVID levels in Q3. Whereas exports discretionary segment is getting ramped up on quarter-on-quarter (QoQ) basis and will take 2-3 quarters to reach pre-COVID levels."

"Export demand is seeing 10 percent decline on a year-on-year (YoY) basis, Gogri mentioned. “COVID impact is still there in the international market,” he added.

He believes the margins have improved for the overall pharma segment.

For more, watch video...

(Edited by : Bivekananda Biswas)

First Published:Nov 20, 2020 3:37 PM IST